BlueStar is a diabetes mobile app that only patients with a prescription will be able to have access to. With the app, patients will be able to monitor and analyze their glucose readings, plus receive real-time coaching on how to handle their particular case of diabetes.
Unlike a lot of novel health-focused apps out there, BlueStar is centered around diagnosis and treatment. And since the BlueStar app makes recommendations on medicine doses and when medications should be taken, the app sought and received clearance from the FDA.
To request access to a download of the BlueStar diabetes mobile app, patients can fill out a form on its website to be notified of when the app will be available in their area.
What Makes This Trend Stand Out
- Prescription-requiring Apps
- The trend of prescription-requiring apps allows for more personalized and medically regulated healthcare solutions.
- Glucose Monitoring and Analysis
- The trend of glucose monitoring and analysis apps provides patients with real-time data insights for better diabetes management.
- Fda-approved Mobile Health Apps
- The trend of FDA-approved mobile health apps establishes a higher standard of safety and reliability in the digital healthcare industry.
Sectors Adopting This
- Healthcare Technology
- The healthcare technology industry can explore disruptive innovation opportunities by developing more prescription-requiring apps for various medical conditions.
- Mobile Health
- The mobile health industry can benefit from disruptive innovation by creating more apps that enable glucose monitoring and analysis, providing vital insights to patients with chronic conditions.
- Regulatory Compliance
- The regulatory compliance industry can capitalize on disruptive innovation opportunities by assisting digital health app developers in obtaining FDA approval for their products.
